ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

QGLY The Quigley (MM)

1.8501
0.00 (0.00%)
27 Sep 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
The Quigley (MM) NASDAQ:QGLY NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.8501 0 01:00:00

The Quigley Corporation to Announce Second Quarter Results and Host Audio Web Cast

30/07/2009 12:00pm

PR Newswire (US)


The Quigley (MM) (NASDAQ:QGLY)
Historical Stock Chart


From Sep 2019 to Sep 2024

Click Here for more The Quigley (MM) Charts.
DOYLESTOWN, Pa., July 30 /PRNewswire-FirstCall/ -- The Quigley Corporation, (NASDAQ:QGLY), http://www.quigleyco.com/ today announced it will issue its second quarter results before market open on Wednesday, August 5, 2009. Ted Karkus, Chairman and CEO, will provide a Company overview including a review of recent activities and second quarter results on a conference call which will be web cast on The Quigley Corporation's web site, (http://www.quigleyco.com/), at 10:00 AM (ET) that morning. A replay of the conference call will be available for 30 days on the Company web site. About The Quigley Corporation The Quigley Corporation (NASDAQ:QGLY) (http://www.quigleyco.com/) is a diversified natural health medical science company. Its Cold Remedy segment is a leading marketer and manufacturer of the COLD-EEZE family of lozenges, gums and sugar free tablets clinically proven to significantly reduce the severity and duration of the common cold. COLD-EEZE customers include leading national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. The Quigley Corporation has several wholly owned subsidiaries including Quigley Manufacturing Inc., which consists of an FDA approved facility to manufacture COLD-EEZE lozenges and fulfill other contract manufacturing opportunities, and Quigley Pharma Inc., (http://www.quigleypharma.com/), which conducts research in order to develop and commercialize a pipeline of patented botanical and naturally derived potential prescription drugs. Forward-Looking Statements Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risk, uncertainties and other factors that may cause the Company's actual performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statement. Factors that impact such forward-looking statements include, among others, changes in worldwide general economic conditions, changes in interest rates, government regulations, and worldwide competition. CONTACT: Ted Karkus Media Investor Relations Chairman of the Board, CEO Karen Pineman Carl Hymans The Quigley Corporation G.S. Schwartz & Co. G.S. Schwartz & Co. (215) 345-0919 212.725.4500 212.725.4500 DATASOURCE: The Quigley Corporation CONTACT: Ted Karkus, Chairman of the Board, CEO, The Quigley Corporation, +1-215-345-0919; Media: Karen Pineman, G.S. Schwartz & Co., , or Investor Relations: Carl Hymans, , both of G.S. Schwartz & Co., +1-212-725-4500 Web Site: http://www.quigleyco.com/

Copyright

1 Year The Quigley (MM) Chart

1 Year The Quigley (MM) Chart

1 Month The Quigley (MM) Chart

1 Month The Quigley (MM) Chart

Your Recent History

Delayed Upgrade Clock